Summary
Cytokines are locally produced hormones that alert the innate and specific immune systems. Many cytokines induce, enhance and govern the traffic of leukocytes. An important mechanism in cell trafficking and migration through endothelial basement membranes and connective tissues is the cytokine-regulated production of matrix degrading proteases. The latter include the serine proteinases of plasminogen activation and metalloproteinases such as collagenases, stromelysins and gelatinases. Many cytokines and all known matrix proteinases are glycoproteins and thus occur as sets of glycoforms. The relation between structures and functions of these glycoproteins has already been probed extensively at the protein level but not yet at the carbohydrate level. Attached oligosaccharides target the cytokines and proteinases to specific cellular receptors and matrix binding sites. In addition, a number of cytokines possess lectin-like functions and may thus interact with carbohydrates of the host or parasites. These intermolecular interactions influence for instance the compartmentalisation, the cell- and tissue-specific distribution and the pharmacokinetics of cytokines and proteinases. Attempts were done to deduce structure-function rules for the intramolecular effects of carbohydrates on cytokines and matrix proteinases. The relatively voluminous N-linked sugars downmodulate the specific activities of enzymes and cytokines. Because in host stress reactions (infection, inflammation, trauma) N-linked glycosylation is less efficient, glycosylation may constitute an important regulatory mechanism in the cytokine network and in multi-enzyme cascades.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adolf, G.R., Kalsner, I., Ahorn, H., Maurer-Fogy, I., and Cantell, K., 1991, Natural human interferon-α2 is O-glycosylated, Biochem. J. 276: 511–518.
Cebon, J., Nicola, N., Ward, M., Gardner, I., Dempsey, P., Layton, J., Durhrsen, U., Burgess, A.W., Nice, E., and Morstyn, G., 1990, Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity, J. Biol. Chem. 265:4483–4491.
Cerretti, D.P., Kozlosky, C.J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.A., March, C.J., Kronheim, S.R., Druck, T., Cannizzaro, L.A., Huebner, K., and Black, R.A., 1992, Molecular cloning of the interleukin-lß converting enzyme, Science 256:97–100.
de Munk, G.A., Parkinson, J.F., Groeneveld, E., Bang, N.U., and Rijken, D.C., 1993, Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin, Biochem. J. 290:655–659. K., 1991, Clearing up glycoprotein hormones, Cell 67:1029–1032.
Dijkmans, R., Heremans, H., and Billiau, A., 1987, Heterogeneity of Chinese hamster ovary cell-produced recombinant interferon-g, J. Biol. Chem. 262:2528–2535.
Drickamer, K., 1991, Clearing up glycoprotein hormones, Cell 67:1029–1032.
Fleer, R., Chen, X.J., Amellal, N., Yeh, P., Fournier, A., Guinet, F., Gault, N., Faucher, D., Folliard, F., Fukuhara, H., and Mayaux, J.-F., 1991, High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis, Gene 107:285–295.
George, A.J.T., 1994, Surface-bound cytokines-a possible effector mechanism in bacterial immunity?, Immunol. Today 15:88–89.
Hasegawa, M., 1993, A thermodynamic model for denaturation of granulocyte colony-stimulating factor: O-linked sugar chain suppresses not the triggering deprotonation but the succeeding denaturation, Biochim. Biophys. Acta. 1203:295–297.
Ishii, K., Yamagami, S., Tanaka, H., Motoki, M., Suwa, Y. and Endo, N., 1995, Full active baculovirus-expressed human monocyte chemoattractant protein 1 with the intact N-terminus, Biochem. Biophys. Res. Comm. 206:955–961.
Kodama, S., Tsujimoto, M., Tsuruoka, N., Sugo, T., Endo, T., and Kobata, A., 1993, Role of sugar chains in the in-vitro activity of recombinant human interleukin 5, Eur. J. Biochem. 211:903–908.
Kunimoto, D.Y., Allison, K.C., Watson, C., Fuerst, T., Armstrong, G.D., Paul, W., and Strober, W., 1991, High-level production of murine interleukin-5 (IL-5) utilising recombinant baculovirus expression. Purification of the rill-5 and its use in assessing the biologic role of IL-5 glycosylation. Cytokine 3:224–230.
Livi, G.P., Ferrara, A.A., Roskin, R., Simon, Pl., and Young, Pr., 1990, Secretion of N-glycosylated human recombinant interleukin-1 alpha in Saccharomyces cerevisiae. Gene 88:297–301.
Livi, G.P., Lillquist, J.S., Miles, L.M., Ferrara, A., Sathe, G.M., Simon, PI., Meyers, CA., Gorman, J.A., Young, Pr., 1991, Secretion of N-glycosylated interleukin-1 beta in Saccharomyces cerevisiae using a leader peptide from Candida albicans. Effect of N-glycosylation on biological activity, J. Biol. Chem. 266:15348–15355.
Lucas, R., Magez, S., De Leys, R., Fransen, L., Scheerlinck, J.P., Rampelberg, M., Sablon, E., and De Baetselier, P., 1994, Mapping the lectin-like activity of tumor necrosis factor, Science 263:814–817.
Marchese, E., Vita, N., Maureaud, T., Ferrara, P., 1990, Separation by cation-exchange high-performance liquid chromatography of three forms of Chinese hamster ovary cell-derived recombinant human interleukin-2, J. Chromatogr. 504:351–358.
Masure, S., Nys, G., Fiten, P., Van Damme, J., and Opdenakker, G., 1993, Mouse gelatinase B: cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation, Eur. J. Biochem. 218:129–141.
Masure, S., and Opdenakker, G. 1989, Cytokine-mediated proteolysis in tissue remodelling, Experientia 45:542–549.
Michaëlsson, E., Malmstrom, V., Reis, S., Engstrom, A., Burkhardt, H., and Holmdahl, R., 1994, T cell recognition of carbohvdrates on type II collagen, J. Exp. Med. 180:745–749.
Mori, K., Dwek, R.A., Downing, A.K., Opdenakker, G., and Rudd, P.M., 1995, The activation of type 1 and type 2 plasminogen by type 1 and type 2 tissue plasminogen activator, J. Biol. Chem. 270:3261–3267.
Mutsaers, J.H.G.M., Kamerling, J.P., Devos, R., Guisez, Y., Fiers, W., and Vliegenthart, J.F.G., 1986, Structural studies of the carbohydrate chains of γ-interferon, Eur. J. Biochem. 156:651–654.
Nairn, H.Y., and Lentze, M.J., 1992, Impact of O-glycosylation on the function of human intestinal lactase-phlorizin hydrolase. Characterization of glycoforms varying in enzyme activity and localization of O-glycoside addition, J. Biol. Chem. 267:25494–25504.
Nissen, C., Dalle Carbonare, V., and Moser, Y., 1994, In vitro comparison of the biological potency of glycosylated versus nonglycosylated rG-CSF, Drug invest. 7:346–352.
Oh-eda, M., Hasegawa, M., Hattori, K., Kuboniwa, H., Kojima, T., Orita, T., Tomonou, K., Yamazaki, T., and Ochi, N., 1990, O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity, J. Biol. Chem. 265:11432–11435.
Opdenakker, G., Cabeza-Arvelais, Y., and Van Damme, J., 1989, Interaction of interferon with other cytokines, Experientia 45:513–520.
Opdenakker, G., Rudd, P.M., Ponting, C.P., and Dwek, R.A., 1993, Concepts and principles of glycobiology, FASEB J. 7:1330–1337.
Opdenakker, G., Rudd, P.M., Wormald, M., Dwek, R.A., and Van Damme, J., 1995, Cells regulate the activities of cytokines by glycosylation, FASEB J. 9:453–457.
Opdenakker, G., and Van Damme, J., 1992, Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer, Cytokine 4:251–258.
Opdenakker, G., and Van Damme J., 1994, Cytokine-induced proteolysis in autoimmune diseases, Immunol. Today 15:104–107.
Opdenakker, G., Van Damme, J., Bosman, F., Billiau, A., and De Somer, P., 1986, Influence of carbohydrate side-chains on activity of tissue-type plasminogen activator, Proc. Soc. Exp. Biol. Med. 182:248–257.
Parekh, R.B., Dwek, R.A., Thomas, J.R., Opdenakker, G., Rademacher, T.W., Wittwer, A.J., Howard, S.C., Nelson, R., Siegel, N.R., Jennings, M.G., Harakas, N.K., and Feder, J., 1989, Cell-type-speciflc and site-specific N-glycosylation of type I and type II human tissue plasminogen activator, Biochemistry 28:7644–7662.
Parekh, R.B., Dwek, R.A., Rademacher, T.W., Opdenakker, G., Van Damme, J., 1992, Glycosylation of interleukin-6 from normal human blood mononuclear cells, Eur. J. Biochem. 203:135–141.
Parkinson, J.F., Vlahos, C.J., Yan, S.C., and Bang, N.U., 1992, Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain, Biochem. J. 283:151–157.
Pos, O., van der stelt, M.E., Wolbink, G.J., Nijsten, M.W., van der Tempel, G.L., and van Dijk, W., 1990, Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels, Clin. Exp. Immunol. 82:579–582.
Rademacher, T.W., Parekh, R.B., and Dwek, R.A., 1988, Glycobiology, Ann. Rev. Biochem. 57:785–838.
Riske, F.J., Cullen, B.R., Chizzonite, R., 1991, Characterisation of human interferon-gamma and human interleukin-2 from recombinant mammalian cell lines and peripheral blood lymphocytes, Lymphokine and Cytokine Res. 10:213–218.
Rudd, P.M., Joao, H.C., Coghill, E., Fiten, P., Saunders, M.R., Opdenakker, G., and Dwek, R.A., 1994, Glycoformsmodify the dynamic stability and functional activity af an enzyme, Biochemistry 33:17–22.
Rudd, P.M., Woods, R.J., Wormald, M.R., Opdenakker, G., Downing, A.K., Campbell, I.D., and Dwek, R.A., 1995, The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator, Biochim. Biophys. Acta 1248:1–10.
Sherblom, A.P., Sathyamoorthy, N., Decker, J.M., and Muchmore, A.V., 1989, IL-2, a lectin with specificity for high-mannose glycopeptides, J. Immunol. 143:939–944.
Tanner, J.E., Goldman, N.D., and Tosato, G., 1990, Biochemical and biological analysis of human interleukin 6 expressed in rodent and primate cells, Cytokine 2:363–374.
Thor, G., Brian, A.A., 1992, Glycosylation variants of murine interleukin-4: evidence for different functional properties, Immunology 75:143–149.
Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., Elliston, K.O., Ayala, J.M., Casano, F.J., Chin, J., Ding, G. J.-F., Egger, L.A., Gaffney, E.P., Limjuco, G., Palyha, O.C., Raju, S.M., Rolando, A.M., Salley, J.P., Yamin, T.-T., Lee, T.D., Shively, J.E., MacCross, M., Mumford, R.A., Schmidt, J.A., and Tocci, M.J., 1992, A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes, Nature 356:768–774.
Tominaga, A., Takahashi, T., Kikuchi, Y., Mita, S., Naomi, S., Harada, N., Yamaguchi, N., and Takatsu, K., 1990, Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5, J. Immunol. 144:1345–1352.
Van Damme, J., De Ley, M., Opdenakker, G., Billiau, A., De Somer, P., and Van Beeumen, J., 1985, Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1, Nature 314:266–268.
Wittwer, A.J., Howard, S.C., Carr, L.S., Harakas, N.K., Feder, J., Parekh, R.B., Rudd, P.M., Dwek, R.A., Rademacher, T.W., 1989, Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator, Biochemistry 28:7662–7669.
Ziltener, H.J., 1993, Glycosylation does not affect in vitro biological activity of interleukin-3, Cytokine 5:291–297.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Van den Steen, P., Rudd, P.M., Dwek, R.A., Van Damme, J., Opdenakker, G. (1998). Cytokine and Protease Glycosylation as a Regulatory Mechanism in Inflammation and Autoimmunity. In: Axford, J.S. (eds) Glycoimmunology 2. Advances in Experimental Medicine and Biology, vol 435. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5383-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5383-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7457-2
Online ISBN: 978-1-4615-5383-0
eBook Packages: Springer Book Archive